Technology
July 17, 2012 — Panasonic announced a new 3-D medical-grade 32-inch class monitor, the EJ-MDA32U-K. The new 3-D monitor is fully compliant with medical equipment standards, delivers exceptional 2-D and 3-D image quality, and can display multiple images from various sources at once. These combined features, paired with Panasonic’s renowned reliability, make the new monitor ideal for use in the surgical bubble.
July 17, 2012
News
July 17, 2012 — New analysis from Frost & Sullivan, “European Data Storage Market in Healthcare,” finds that the market earned revenues of $1,011.4 million in 2010 and estimates this to reach $2,473 million in 2017. The research covers hospital IT, research and imaging segments.
July 17, 2012
Feature | Kamran Zamanian, Ph.D.
As the average age of the U.S. population and the number of patients at high risk for cardiovascular disease increase, the usage of cardio and endovascular stents continues to grow. Interventional cardiologists and registered nurses in the U.S. were recently asked about their perceptions and attitudes regarding current percutaneous coronary interventional (PCI) procedures and devices. They were also asked their stent brand and drug type preferences. In a statistically significant survey, they divulged which procedures and manufactures they preferred. This window into micro level stent usage offers informed insights into the overall market and reveals how dynamics between medical organizations and device manufacturers contribute to market trends.
July 17, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
July 17, 2012 — Arterial Remodeling Technologies (ART) reported that they have achieved a medical milestone with its Arterial Remodeling Transient DIsmantling Vascular Angioplasty (ARTDIVA) clinical trial: The successful first-in-human implantation of its novel biodegradable stent into an 61-year-old male who was suffering from a blocked coronary artery and needed a percutaneous coronary intervention (PCI).
July 17, 2012
Technology
July 16, 2012 — TriReme Medical Inc. (TMI) announced today that it has received U.S. Food and Drug Administration (FDA) clearance for an expanded matrix of sizes for its unique Glider PTCA balloon catheter.
July 16, 2012News
Mercator MedSystems, a medical technology company whose platform Micro-Infusion Catheter technology announced preliminary results of its DANCE clinical trial that continues to follow patients at the University of California, San Francisco (UCSF) and San Francisco VA Medical Center. The technology offers catheter-guided, microfluid injection systems for site-specific, nonsystemic delivery of therapeutic agents directly across any peripheral or coronary blood vessel to treat peripheral vascular diseases, cancer, heart attacks, and other life-threatening diseases and disorders.
July 16, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature
July 16, 2012 — The American College of Cardiology (ACC) and the American College of Radiology (ACR) are warning that the extreme cuts to funding for medical imaging scans in the 2013 Medicare Physician Fee Schedule Proposed Rule are unnecessary, unfounded and will undermine patient care.
July 16, 2012
News
July 16, 2012 — Reva Medical Inc. announced it completed clinical enrollment with the ReZolve drug-eluting bioresorbable scaffold. A total of 26 patients have been enrolled and there are no major adverse coronary events (MACE) reported to date.
July 16, 2012News
July 16, 2012 — LipoScience Inc., an in vitro diagnostic company developing clinical diagnostic tests using nuclear magnetic resonance (NMR) technology, announced publication of the findings of a clinical study in the current issue of the Journal of the American College of Cardiology indicating that high density lipoprotein (HDL) particle number has a stronger, more independent association with coronary heart disease and carotid atherosclerosis than HDL cholesterol (HDL-C).
July 16, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023Feature | Kevin E. Steel, D.O., FACC, Cardiologist
July 16, 2012 — Medical imaging has always been an important part of clinical trials. Echocardiography, which uses sound waves to create moving real-time images of cardiac structure and function, provides an excellent noninvasive method to evaluate the impact of therapeutics on cardiac morphology.
July 16, 2012News
July 16, 2012 — The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $4.78 million grant to researchers at Cleveland Clinic’s Lerner Research Institute to use metabolomics — a new approach that focuses on the small-molecule byproducts of metabolism — for discovery of novel pathways linked to the development of cardiovascular diseases.
July 16, 2012News
July 16, 2012 — Cardiosolutions Inc., an early-stage company focused on the development of an innovative percutaneous system to treat patients with moderate to severe mitral valve regurgitation, today announced it has received a minority investment from Sorin Group. Sorin is a global medical device company and develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.
July 16, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
July 16, 2012 — The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of Alere Triage products. Identified lots may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results.
July 16, 2012
Feature | Partho P Sengupta, M.D., DM, FASE
Echocardiography is a natural application for telemedicine, as handheld ultrasound devices and cloud-based transmission solutions make it possible to perform a test at a remote location and have consultation, in real time, by an expert thousands of miles away. Telemedicine can eliminate the need for travel, reduce wait time for test results, and is cost effective.
July 13, 2012
News
July 13, 2012 — GE Healthcare and VPDiagnostics Inc. jointly announced today their co-marketing agreement for the VPDiagnostics’ MRI-PlaqueView software for carotid artery atherosclerosis analysis.
July 13, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now